Summary

Multiplex PCR Market – Scope of Report
TMR’s report on the global multiplex PCR market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global multiplex PCR market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global multiplex PCR market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the multiplex PCR market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global multiplex PCR market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global multiplex PCR market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global multiplex PCR market.

The report delves into the competitive landscape of the global multiplex PCR market. Key players operating in the global multiplex PCR market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global multiplex PCR market profiled in this report.

Key Questions Answered in Global multiplex PCR Market Report
• What is the sales/revenue generated by multiplex PCR across all regions during the forecast period?
• What are the opportunities in the global multiplex PCR market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Multiplex PCR Market – Research Objectives and Research Approach
The comprehensive report on the global multiplex PCR market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global multiplex PCR market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global multiplex PCR market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Multiplex PCR Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Multiplex PCR Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Multiplex PCR Market Analysis and Forecast, by Products & Services
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Products & Services, 2020-2034
6.3.1. Consumables
6.3.2. Instruments
6.3.3. Software’s and Services
6.4. Market Attractiveness, by Products & Services
7. Global Multiplex PCR Market Analysis and Forecast, by Assay Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Assay Type, 2020-2034
7.3.1. Planar Assay
7.3.1.1. Blends Protein Assays (Multiplexed ELISA)
7.3.1.2. Antibody Assays
7.3.2. Bead-based Assay
7.3.2.1. Magnetic Bead-based
7.3.2.2. Non-Magnetic Bead-based
7.3.3. 7.4 Market Attractiveness, by Assay Type
8. Global Multiplex PCR Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Disease Diagnosis
8.3.2. Research & Development
8.3.3. Others (Clinical Diagnostics, etc.)
8.4. Market Attractiveness, by Application
9. Global Multiplex PCR Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Biopharmaceutical Companies
9.3.2. Clinical Research Organizations
9.3.3. Academic Research Institutes
9.3.4. Others (Diagnostic Centers, etc.)
9.4. Market Attractiveness, by End-user
10. Global Multiplex PCR Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Multiplex PCR Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Products & Services, 2020-2034
11.2.1. Consumables
11.2.2. Instruments
11.2.3. Software’s and Services
11.3. Market Attractiveness, by Products & Services
11.4. Market Value Forecast, by Assay Type, 2020-2034
11.4.1. Planar Assay
11.4.1.1. Blends Protein Assays (Multiplexed ELISA)
11.4.1.2. Antibody Assays
11.4.2. Bead-based Assay
11.4.2.1. Magnetic Bead-based
11.4.2.2. Non-Magnetic Bead-based
11.5. Market Attractiveness, by Assay Type
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Disease Diagnosis
11.6.2. Research & Development
11.6.3. Others (Clinical Diagnostics, etc.)
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Biopharmaceutical Companies
11.8.2. Clinical Research Organizations
11.8.3. Academic Research Institutes
11.8.4. Others (Diagnostic Centers, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Products & Services
11.11.2. By Assay Type
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Multiplex PCR Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Products & Services, 2020-2034
12.2.1. Consumables
12.2.2. Instruments
12.2.3. Software’s and Services
12.3. Market Attractiveness, by Products & Services
12.4. Market Value Forecast, by Assay Type, 2020-2034
12.4.1. Planar Assay
12.4.1.1. Blends Protein Assays (Multiplexed ELISA)
12.4.1.2. Antibody Assays
12.4.2. Bead-based Assay
12.4.2.1. Magnetic Bead-based
12.4.2.2. Non-Magnetic Bead-based
12.5. Market Attractiveness, by Assay Type
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Disease Diagnosis
12.6.2. Research & Development
12.6.3. Others (Clinical Diagnostics, etc.)
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Biopharmaceutical Companies
12.8.2. Clinical Research Organizations
12.8.3. Academic Research Institutes
12.8.4. Others (Diagnostic Centers, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Products & Services
12.11.2. By Assay Type
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Multiplex PCR Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Products & Services, 2020-2034
13.2.1. Consumables
13.2.2. Instruments
13.2.3. Software’s and Services
13.3. Market Attractiveness, by Products & Services
13.4. Market Value Forecast, by Assay Type, 2020-2034
13.4.1. Planar Assay
13.4.1.1. Blends Protein Assays (Multiplexed ELISA)
13.4.1.2. Antibody Assays
13.4.2. Bead-based Assay
13.4.2.1. Magnetic Bead-based
13.4.2.2. Non-Magnetic Bead-based
13.5. Market Attractiveness, by Assay Type
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Disease Diagnosis
13.6.2. Research & Development
13.6.3. Others (Clinical Diagnostics, etc.)
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Biopharmaceutical Companies
13.8.2. Clinical Research Organizations
13.8.3. Academic Research Institutes
13.8.4. Others (Diagnostic Centers, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Products & Services
13.11.2. By Assay Type
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Multiplex PCR Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Products & Services, 2020-2034
14.2.1. Consumables
14.2.2. Instruments
14.2.3. Software’s and Services
14.3. Market Attractiveness, by Products & Services
14.4. Market Value Forecast, by Assay Type, 2020-2034
14.4.1. Planar Assay
14.4.1.1. Blends Protein Assays (Multiplexed ELISA)
14.4.1.2. Antibody Assays
14.4.2. Bead-based Assay
14.4.2.1. Magnetic Bead-based
14.4.2.2. Non-Magnetic Bead-based
14.5. Market Attractiveness, by Assay Type
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Disease Diagnosis
14.6.2. Research & Development
14.6.3. Others (Clinical Diagnostics, etc.)
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Biopharmaceutical Companies
14.8.2. Clinical Research Organizations
14.8.3. Academic Research Institutes
14.8.4. Others (Diagnostic Centers, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Products & Services
14.11.2. By Assay Type
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Multiplex PCR Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Products & Services, 2020-2034
15.2.1. Consumables
15.2.2. Instruments
15.2.3. Software’s and Services
15.3. Market Attractiveness, by Products & Services
15.4. Market Value Forecast, by Assay Type, 2020-2034
15.4.1. Planar Assay
15.4.1.1. Blends Protein Assays (Multiplexed ELISA)
15.4.1.2. Antibody Assays
15.4.2. Bead-based Assay
15.4.2.1. Magnetic Bead-based
15.4.2.2. Non-Magnetic Bead-based
15.5. Market Attractiveness, by Assay Type
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Disease Diagnosis
15.6.2. Research & Development
15.6.3. Others (Clinical Diagnostics, etc.)
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Biopharmaceutical Companies
15.8.2. Clinical Research Organizations
15.8.3. Academic Research Institutes
15.8.4. Others (Diagnostic Centers, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Products & Services
15.11.2. By Assay Type
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Thermo Fisher Scientific
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Bio-Rad Laboratories, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. QIAGEN N.V.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Luminex Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Standard BioTools Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. BioFire Diagnostics
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Becton, Dickinson and Company
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. DiaSorin
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Seegene Inc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Illumina, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview